ECSP982741A - COMBINED THERAPY FOR THE TREATMENT OF AIDS - Google Patents
COMBINED THERAPY FOR THE TREATMENT OF AIDSInfo
- Publication number
- ECSP982741A ECSP982741A ECSP982741A ECSP982741A EC SP982741 A ECSP982741 A EC SP982741A EC SP982741 A ECSP982741 A EC SP982741A EC SP982741 A ECSP982741 A EC SP982741A
- Authority
- EC
- Ecuador
- Prior art keywords
- aids
- reverse transcriptase
- hiv
- treatment
- methods
- Prior art date
Links
- 208000030507 AIDS Diseases 0.000 title abstract 3
- 238000002648 combination therapy Methods 0.000 title 1
- 230000005764 inhibitory process Effects 0.000 abstract 2
- 239000003419 rna directed dna polymerase inhibitor Substances 0.000 abstract 2
- 229940126062 Compound A Drugs 0.000 abstract 1
- 208000031886 HIV Infections Diseases 0.000 abstract 1
- 108010010369 HIV Protease Proteins 0.000 abstract 1
- 108010078851 HIV Reverse Transcriptase Proteins 0.000 abstract 1
- 208000037357 HIV infectious disease Diseases 0.000 abstract 1
- 229940122440 HIV protease inhibitor Drugs 0.000 abstract 1
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 abstract 1
- 229940122313 Nucleoside reverse transcriptase inhibitor Drugs 0.000 abstract 1
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 229940088710 antibiotic agent Drugs 0.000 abstract 1
- 239000003443 antiviral agent Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 239000004030 hiv protease inhibitor Substances 0.000 abstract 1
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 abstract 1
- 239000002955 immunomodulating agent Substances 0.000 abstract 1
- 229940121354 immunomodulator Drugs 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 239000002773 nucleotide Substances 0.000 abstract 1
- 125000003729 nucleotide group Chemical group 0.000 abstract 1
- 229940042443 other antivirals in atc Drugs 0.000 abstract 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La combinación del compuesto A inhibidor de proteasa VIH, y uno o más inhibidores nucleósidos de transcriptasa reversa, inhibidores no-nucñeósidos de transcriptasa reversa o inhibidores de proteasa es útil en la inhibición de proteasa VIH, la inhibición de transcriptasa reversa de VIH, la prevención o tratamiento del sida, sea como compuestos, sales o ésteres farmacéuticamente aceptables, ingredientes de composición farmacéutica, estén o no en combinación con otros antivirales, inmunomoduladores, antibióticos o vacunas. Se describen también métodos de tratamiento del SIDA y métodos de prevención o tratamiento de infección por VIH.The combination of compound A HIV protease inhibitor, and one or more nucleoside reverse transcriptase inhibitors, non-nucleotide reverse transcriptase inhibitors or protease inhibitors is useful in HIV protease inhibition, HIV reverse transcriptase inhibition, prevention or AIDS treatment, either as pharmaceutically acceptable compounds, salts or esters, ingredients of pharmaceutical composition, whether or not in combination with other antivirals, immunomodulators, antibiotics or vaccines. Also described are methods of treating AIDS and methods of preventing or treating HIV infection.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP982741 ECSP982741A (en) | 1998-11-12 | 1998-11-12 | COMBINED THERAPY FOR THE TREATMENT OF AIDS |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP982741 ECSP982741A (en) | 1998-11-12 | 1998-11-12 | COMBINED THERAPY FOR THE TREATMENT OF AIDS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP982741A true ECSP982741A (en) | 1999-04-21 |
Family
ID=42043660
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP982741 ECSP982741A (en) | 1998-11-12 | 1998-11-12 | COMBINED THERAPY FOR THE TREATMENT OF AIDS |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP982741A (en) |
-
1998
- 1998-11-12 EC ECSP982741 patent/ECSP982741A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9204720A (en) | QUINAZOLINE DERIVATIVES AS HIV REVERSE TRANSCRIPTASE INHIBITORS. | |
| DE60036961D1 (en) | GAMMA-HYDROXY-2- (FLUORALKYLAMINOCARBONYL) -1-PIPERAZINE PENTANAMIDE AS AN HIV PROTEASE INHIBITOR | |
| MX9304775A (en) | BENZOXAZINONES AS REVERSE HIV TRANSCRIPTASE INHIBITORS. | |
| DE69228106D1 (en) | HIV protease inhibitors | |
| CR9694A (en) | HIV REVERSE TRANSCRIPT INHIBITORS | |
| EP0766674A4 (en) | NOVEL HIV PROTEASE INHIBITORS | |
| BR9406503A (en) | Combination of compounds, pharmaceutical composition and processes to treat AIDS to prevent and treat HIV infection and to inhibit HIV protease | |
| BR9408305A (en) | Compound pharmaceutical composition processes for the treatment of AIDS and HIV infection for the preparation of HIV infection and for inhibition of HIV protease and combination of compounds | |
| MX9302681A (en) | NEW QUINAZOLINS AS REVERSE HIV TRANSCRIPTASE INHIBITORS. | |
| MX9705916A (en) | Combination therapy for hiv infection using the hiv protease inhibitor indinavir adn the reverse transcriptase inhibitor 3tc, optionally together with azt, ddi or ddc. | |
| MX9700036A (en) | Combination therapy for hiv infection. | |
| AR013758A1 (en) | COMBINATION THERAPY FOR THE TREATMENT OF AIDS. | |
| ECSP982741A (en) | COMBINED THERAPY FOR THE TREATMENT OF AIDS | |
| MX9701121A (en) | Hiv protease inhibitor combination. | |
| ECSP961660A (en) | COMBINED THERAPY FOR HIV INFECTION | |
| FI970565A0 (en) | HIV proteasinhibitorkombination | |
| ECSP088126A (en) | HIV REVERSE TRANSCRIPT INHIBITORS | |
| DOP2001000263A (en) | AZA AND POLIAZA-NAFTALENIL CARBOXAMIDES USEFUL AS INHIBITORS OF HIV INTEGRESS |